VIROMARKERS presentations at ICAR 2026

The VIROMARKERS team proudly brought the project to the Italian Conference on AIDS and Antiviral Research (ICAR 2026), held in Catania, Italy from 20 to 22 May 2026.

Here the conference website: https://www.icar2026.com/index.php

A great opportunity to present the project, share and discuss innovation and connect with the scientific community working on HIV and antiviral research!

We are also proud to announce that two contributions were selected among the finalists for Best Abstract in the Basic Science category.

Congratulations to the team!

Check below all our oral presentations and scientific posters, showcasing our latest research data and findings!

Oral presentations:

Multidisciplinary assessment of the HIV-1 reservoir after switching from triple to dual antiretroviral therapy in virologically suppressed individuals, a prospective observational pilot study

Lia Fiaschi (UniSiena) Best Abstract finalist in "Basic Science" Category

CMV-RNA kinetics in allo-HSCT patients: optimizing viral surveillance during and after letermovir prophylaxis

Caterina Tramontozzi (UTOV) Best Abstract finalist in "Basic Science" Category

Chronic HDV infection is characterized by distinct profiles of HBsAg isoforms underlying different disease stages

Ilaria Grossi (UTOV)

Genetic diversity in hepatitis Delta antigen and ribozyme is associated with altered virological and biochemical markers and could help identify novel therapeutic targets

Stefano D’Anna (UTOV)

Posters:

HBV Replicative Activity by highly-sensitive droplet-digital-PCR in PWH Switching to CAB/RPV-LA therapy: preliminary results from the OBILART STUDY

Alessia Magnapera (UTOV)

Broad genetic diversity of HDV and high prevalence of active HDV infection in Cameroon: insights from molecular diagnostics and whole-genome sequencing

Lorenzo Piermatteo (UTOV)